Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects.
about
The prevalence of the metabolic syndrome in Korean adults: comparison of WHO and NCEP criteriaCardiac Remodeling from Middle Age to SenescenceThe metabolic syndrome X.Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals.Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction.The dysmetabolic syndrome.Genome scan for loci regulating HDL cholesterol levels in Finnish extended pedigrees with early coronary heart diseasePrevalence of metabolic syndrome in bus and truck drivers in Kashan, Iran.The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).Incidence of Metabolic Syndrome and Its Risk Factors among Type 2 Diabetes Clinic Attenders in Isfahan, Iran.Blood rheology and platelet function in untreated early-stage essential hypertensives complicated with metabolic syndrome.Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central IndiaPrevalence of metabolic syndrome among newly diagnosed hypertensive patients in the hills of Himachal Pradesh, IndiaMetabolic syndrome and target organ damage: role of blood pressure.Prevalence of metabolic syndrome in an adult urban population of the west of Iran.Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.Non-dipping pattern in ambulatory blood pressure monitoring is associated with metabolic abnormalities in a random sample of middle-aged subjects.The fat mass and obesity-associated (FTO) gene variant rs9939609 predicts long-term incidence of cardiovascular disease and related death independent of the traditional risk factors.Metabolic Syndrome and Framingham Risk Score: Observation from Screening of Low-Income Semi-Urban African Women.Muscle fiber type I influences lipid oxidation during low-intensity exercise in moderately active middle-aged men.Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines.Plasma adiponectin concentration is associated with ambulatory daytime systolic blood pressure but not with the dipping status.Body weight variation and control of cardiovascular risk factors in essential hypertension.Glomerular filtration rate is related to dipping pattern in ambulatory blood pressure monitoring--a cross-sectional population-based study.Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus.Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness.Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort.[Analysis of the criteria used for the definition of metabolic syndrome in patients with type 2 diabetes mellitus].Preproghrelin Leu72Met polymorphism in patients with type 2 diabetes mellitus.Tyrosine phosphatase 1B and leptin receptor genes and their interaction in type 2 diabetes.Increased daily sodium intake is an independent dietary indicator of the metabolic syndrome in middle-aged subjects.Resting heart rate as a predictor of body weight gain in the early stage of hypertension.Leptin and lipid metabolism in chronic kidney failure.Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients.Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study.Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease.IGF-I concentrations are positively associated with carotid artery atherosclerosis in women.
P2860
Q33659059-EDBFD3B3-5C8D-44ED-AD90-702B7FDE7D62Q33729574-716BCB55-CFCA-47B6-ADE5-94774F7DC5D0Q33936947-43B1A8C3-6364-415B-8CE8-3385554A2AF1Q33954488-5E6F23B1-0E42-4CE3-BB6C-C6D97B2F5650Q34159728-44280BC4-F5CA-4BBD-A886-7530FE3842D9Q34328284-D23992E6-C3D9-4EB0-B06B-419C02E6A0FBQ34329091-3171A491-EC55-4894-8E72-A7FF40CB6CF3Q35052686-3B88C161-8AA6-4ADD-ACB5-2071DBB42B21Q35135723-4D49761E-89F3-4B97-A3A6-DCD5FBDE1171Q35841934-45E28060-ADF1-4E69-AC05-B0D2B3BA0192Q35855960-4B663E00-C112-4CD7-AB85-CE391D440123Q35915412-EF0B926A-083B-4D6E-B8AF-912110EFF33AQ36306317-21C02C7A-2FA0-47F5-8F3B-CC006F0D3EE1Q36647948-734D919B-92DA-4C63-AFF4-B057529EB530Q37095128-8B528DA9-9ACE-4477-AFBD-3D7E9ECDC5B4Q37176461-06A0E319-9EC1-443B-9E26-09F94DF6958AQ37412122-14BDDC6D-0628-4EFB-BC04-FB1B6FC58B47Q37657417-D87E6837-3C13-4A7E-945F-878AFBF84BF2Q39720393-03787A54-001A-418A-9BF9-4DB8AF73ED92Q39949512-B98ACCCF-2FA1-46D2-8C25-49ACF44846C0Q41134529-73DCABFC-4CEA-4321-9E6F-F585BD33D073Q41747873-C2A5959C-F7EE-40B9-AF63-CE5786EBD75FQ42491962-AEC43D4F-D8D1-40FF-BC9A-18B2E093CE04Q43143787-3A29FC18-E6B4-4D5E-9617-68E58A74F469Q43221799-20FFCF09-0D29-4051-BFA9-4898D5919084Q43240499-E1D04227-4381-48BF-83E7-B6FD84F249FEQ43292764-A6F6C42E-65FF-43F3-B63B-D5EFFFEF7030Q43605949-7278A10C-D21D-452A-BEEE-F29CE83CDAA1Q43674604-DBEB9E38-AB4B-4DFE-8826-1C7A1B9FDD31Q43924591-47F5354E-89A4-4523-854A-8E67C1270001Q44198279-1B073EE3-C255-42D7-BB20-8044D931EBE6Q44585250-FC287AA0-A73C-41A3-A74B-A45AB8F213BDQ44930763-85DB42C4-DEF7-4B56-93A6-C03C79B2248DQ45113637-2C978CDB-0C63-4A50-8570-7B1493AF8B20Q45187664-9B0F0B08-6873-4CFB-92DE-9BC3CF815DC7Q46160192-042F9CB9-E286-4E7A-AFB7-83A4547D467FQ46447193-1290B163-634D-41F8-8DB9-3F33B8C58F90Q46607697-81BDE9E9-9008-43C9-B5E1-6A00184C3B24Q46664849-711C10A6-6C3D-4904-BB44-DE6449F6535BQ46716545-85002D72-9245-4C71-B0F4-E057BE683834
P2860
Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Prevalence of the metabolic sy ...... patients and control subjects.
@en
Prevalence of the metabolic sy ...... patients and control subjects.
@nl
type
label
Prevalence of the metabolic sy ...... patients and control subjects.
@en
Prevalence of the metabolic sy ...... patients and control subjects.
@nl
prefLabel
Prevalence of the metabolic sy ...... patients and control subjects.
@en
Prevalence of the metabolic sy ...... patients and control subjects.
@nl
P2093
P2860
P1476
Prevalence of the metabolic sy ...... patients and control subjects.
@en
P2093
Kesäniemi YA
Rantala AO
Reunanen A
Savolainen MJ
P2860
P304
P356
10.1046/J.1365-2796.1999.00429.X
P407
P577
1999-02-01T00:00:00Z